Current Perspectives on Neck Masses: A Review of Clinical Presentation and Diagnostic Approach
- 1. Department of Chemistry, Batterjee Medical College, Saudi Arabia
Abstract
Neck masses present a diagnostic challenge due to their diverse etiologies, including inflammatory, neoplastic, congenital, and infectious causes. They are common, with a prevalence estimated at 14.1% in the general population, and can indicate serious underlying pathology, including malignancies such as lymphoma, thyroid cancer, and metastatic disease. Early detection and management are crucial to ensure optimal patient outcomes.
This review provides a comprehensive overview of neck masses, including their prevalence, etiology, clinical presentation, diagnostic workup, and management strategies. Imaging modalities such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) play a crucial role in the evaluation of neck masses, aiding in accurate diagnosis and treatment planning. Biopsy techniques, including fine-needle aspiration (FNA), are often performed to obtain tissue for histopathological examination, guiding further management decisions.
Recent advances in imaging technologies, such as CT and MRI, have significantly impacted the diagnosis and management of neck masses. These modalities offer improved resolution and better characterization of lesions, aiding in more accurate diagnosis and treatment planning. Advancements in molecular and genetic studies have provided valuable insights into the pathophysiology of neck masses, leading to the identification of specific biomarkers and genetic mutations associated with different types of neck masses. Minimally invasive surgical techniques, such as endoscopic and robotic-assisted surgery, have revolutionized the management of neck masses, offering patients less invasive treatment options with reduced morbidity and faster recovery times.
Future research directions include further refining diagnostic techniques, identifying novel biomarkers, and developing targeted therapies for specific subtypes of neck masses. Collaboration among researchers and clinicians is essential for translating these advancements into clinical practice, ultimately improving the care and quality of life for patients with neck masses.
Keywords
• Neck Masses; Clinical Presentation; Diagnostic Approach; Recent Advances; Future Directions
CITATION
Albaik M (2024) Current Perspectives on Neck Masses: A Review of Clinical Presentation and Diagnostic Approach. J Ear Nose Throat Disord 8(1): 1056
INTRODUCTION
Neck masses represent a common clinical presentation across various age groups and can arise from a myriad of etiologies. They pose a diagnostic challenge due to the wide range of differential diagnoses, including inflammatory, neoplastic, congenital, and infectious causes [1,2]. The prevalence of neck masses varies depending on the population studied and the underlying etiology, with estimates by 14.1% in the general population [3].
The significance of neck masses in clinical practice stems from the potential for serious underlying pathology, including malignancies such as lymphoma, thyroid cancer, and metastatic disease [1]. Early detection and management are crucial to ensure optimal patient outcomes and reduce morbidity and mortality associated with advanced-stage disease [4].
Various imaging modalities, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), play a crucial role in the evaluation of neck masses, aiding in accurate diagnosis and treatment planning. Additionally, fine-needle aspiration (FNA) biopsy is often performed to obtain tissue for histopathological examination, guiding further management decisions [5].
In recent years, significant progress has been made in the diagnosis and management of neck masses. Advanced imaging technologies, such as MRI and positron emission tomography (PET), have improved the characterization of lesions, leading to more accurate diagnoses and personalized treatment approaches [6,7]. Molecular and genetic studies have provided insights into the pathophysiology of neck masses, identifying biomarkers and potential therapeutic targets for personalized medicine approaches [8]. Minimally invasive surgical techniques, including endoscopic and robotic-assisted surgery, have revolutionized the management of neck masses, offering patients less invasive treatment options with reduced morbidity and faster recovery times [9,10].
In this review, we aim to provide a comprehensive overview of neck masses, including their prevalence, etiology, clinical presentation, diagnostic workup, and management strategies. We will also discuss the importance of early detection and management in improving patient outcomes.
ETIOLOGY AND PATHOPHYSIOLOGY
Neck masses can arise from a wide range of etiologies, including inflammatory, neoplastic, congenital, and infectious causes. Inflammatory neck masses often result from reactive lymphadenopathy, which is a response to infections or immune reactions. Common causes include upper respiratory tract infections, dental infections, and autoimmune conditions such as rheumatoid arthritis or systemic lupus erythematosus [11]. Neoplastic causes of neck masses include both benign and malignant tumors, with lymphoma, thyroid cancer, and metastatic disease being among the most common malignancies. Benign neoplasms, such as lipomas and schwannomas, also contribute to the spectrum of neoplastic neck masses [12].
Congenital neck masses are present at birth and can result from developmental anomalies such as branchial cleft cysts, thyroglossal duct cysts, and cystic hygromas. These masses typically present in childhood but can persist into adulthood if left untreated [13]. Other congenital causes include dermoid cysts, teratomas, and vascular anomalies like hemangiomas and lymphangiomas [14].
Infectious etiologies of neck masses include bacterial, viral, and fungal infections [15]. Acute bacterial lymphadenitis is commonly caused by Staphylococcus aureus or Streptococcus pyogenes [16], while viral infections such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV) can also lead to lymphadenopathy [17].
The pathophysiological mechanisms involved in the development of neck masses vary depending on the underlying etiology. Inflammatory neck masses are characterized by reactive hyperplasia of lymphoid tissue in response to antigenic stimulation, often accompanied by cellular infiltration and edema [18]. Neoplastic neck masses arise from uncontrolled proliferation of cells, which can infiltrate surrounding tissues and metastasize to distant sites. Oncogenic mutations and chromosomal translocations, such as those involving the BCL2 gene in follicular lymphoma, are key molecular events in the pathogenesis of neoplastic neck masses [19]. Congenital neck masses result from abnormal embryological development, leading to the formation of cysts or other anomalies, with genetic and environmental factors potentially contributing to their formation [20]. Infectious neck masses are the result of inflammatory responses to microbial invasion, often characterized by necrosis and abscess formation in severe cases [3].
Neck masses can have diverse etiologies, including inflammatory, neoplastic, congenital, and infectious causes. Understanding the underlying pathophysiological mechanisms is crucial for accurate diagnosis and appropriate management.
CLINICAL PRESENTATION
The clinical presentation of neck masses varies depending on the underlying etiology. Common signs and symptoms include palpable neck swelling, pain, tenderness, and changes in size or consistency of the mass. Other associated symptoms may include fever, weight loss, dysphagia, hoarseness, and respiratory distress, depending on the nature and location of the mass [1]. Swelling is often the first noticeable symptom and may be accompanied by localized pain or tenderness, particularly in inflammatory or infectious cases [11]. Other associated symptoms may include fever, weight loss, dysphagia, hoarseness, and respiratory distress, depending on the nature and location of the mass. Fever and weight loss are more indicative of systemic involvement, often seen in infectious or malignant condition. Dysphagia and hoarseness are particularly concerning as they may suggest involvement of the esophagus or vocal cords, respectively [21].
Thorough clinical evaluation is essential in the assessment of neck masses to determine the underlying cause and guide further management. A detailed history should be obtained, including the onset and duration of symptoms, associated symptoms, past medical history, and risk factors for malignancy. Important risk factors to consider include tobacco and alcohol use, history of radiation exposure, and family history of cancer [22]. Physical examination should include inspection and palpation of the neck to assess the size, location, and characteristics of the mass, as well as evaluation of the surrounding structures for any signs of compression or invasion. Palpation helps determine whether the mass is fixed or mobile, soft or hard, and whether it is associated with overlying skin changes, such as erythema or ulceration [21,23].
Differential diagnosis of neck masses is broad and includes benign and malignant etiologies. Common benign causes of neck masses include reactive lymphadenopathy, branchial cleft cysts, and thyroglossal duct cysts. Reactive lymphadenopathy often presents as multiple small, tender, and mobile lymph nodes, usually following an upper respiratory infection [24]. Malignant causes include lymphoma, thyroid cancer, and metastatic disease. Lymphomas typically present as painless, firm, and rubbery lymph nodes, while thyroid cancer may manifest as a solitary thyroid nodule or multinodular goiter [23]. Other less common causes include salivary gland tumors, vascular anomalies, and infectious etiologies. Salivary gland tumors often present as painless masses in the parotid or submandibular glands, and vascular anomalies may present as pulsatile or compressible masses [23,24].
The importance of a systematic approach to the evaluation of neck masses cannot be overstated. Prompt and accurate diagnosis is crucial for initiating appropriate management and optimizing patient outcomes. Imaging studies, such as ultrasound, CT scan, and MRI, play a vital role in further characterizing the mass and guiding biopsy or surgical intervention when indicated [6,11,23]. Ultrasound is particularly useful for initial evaluation, while CT and MRI provide more detailed anatomical information and help assess the extent of the disease [25].
The clinical presentation of neck masses is variable and depends on the underlying etiology. Thorough clinical evaluation, including history taking, physical examination, and appropriate imaging studies, is essential for accurate diagnosis and management.
Diagnostic Workup
The evaluation of neck masses requires a systematic approach that includes imaging studies and biopsy techniques to establish an accurate diagnosis. Common diagnostic modalities used in the evaluation of neck masses include ultrasound, CT scan, MRI, and biopsy techniques.
Ultrasound is often the initial imaging modality of choice for evaluating neck masses due to its accessibility, cost-effectiveness, and ability to differentiate between cystic and solid masses [25]. It provides real-time imaging, which is particularly useful for guiding FNA biopsies. It can also help determine the vascularity of the mass, which can be useful in distinguishing between benign and malignant lesions [26].
CT scan is valuable in further characterizing neck masses, particularly in defining the extent of the lesion and its relationship to adjacent structures. It provides detailed anatomical information and is particularly useful in evaluating bony involvement or metastatic disease. CT scans can reveal calcifications, which are often associated with certain types of tumors, such as papillary thyroid cancer. It is also essential for preoperative planning in cases where surgical intervention is anticipated [6,26].
MRI is another valuable imaging modality for evaluating neck masses, especially for assessing soft tissue involvement and delineating the anatomy of the neck. It is particularly useful in evaluating tumors of the salivary glands, thyroid, and lymph nodes [6]. MRI offers superior contrast resolution compared to CT, which helps in distinguishing different soft tissue structures and in assessing perineural spread of tumors. It is also the preferred imaging modality for patients with contraindications to ionizing radiation, such as pregnant women [27].
Biopsy is often necessary to establish a definitive diagnosis of a neck mass. Fine-needle aspiration (FNA) biopsy is a minimally invasive procedure that can provide cytological information about the nature of the mass, aiding in the differentiation between benign and malignant lesions. FNA is particularly useful for evaluating thyroid nodules and lymphadenopathy, offering a high diagnostic accuracy when combined with ultrasound guidance [28]. Core needle biopsy may be used in cases where FNA is inconclusive or to obtain a larger tissue sample for histopathological examination [29]. This technique is often employed for larger masses or those with a complex architecture that requires a more substantial tissue sample to achieve a definitive diagnosis [30].
The diagnostic workup for neck masses can be summarized as a combination of imaging studies such as ultrasound, CT scan, and MRI, along with biopsy techniques such as FNA and core needle biopsy. In certain cases, additional advanced imaging techniques like positron emission tomography (PET) may be used for further assessment, particularly in oncological settings to evaluate metabolic activity and detect metastases [7]. A multidisciplinary approach involving radiologists, pathologists, and surgeons is often necessary to establish an accurate diagnosis and guide appropriate management. This collaborative approach ensures comprehensive evaluation and optimized treatment planning, tailored to the specific characteristics of each neck mass.
MANAGEMENT
Management of neck masses depends on the underlying etiology and may include conservative management, surgical intervention, and adjuvant therapies.
Conservative Management: In cases of benign inflammatory neck masses, such as reactive lymphadenopathy, conservative management with observation and symptomatic treatment may be sufficient [11]. Antibiotics are indicated for bacterial infections causing neck masses, such as acute bacterial lymphadenitis, with consideration for surgical drainage in cases of abscess formation [31]. Anti-inflammatory medications may be used for pain relief and reduction of inflammation in cases of inflammatory neck masses, and corticosteroids may be considered in more severe cases to reduce inflammation and lymph node swelling [32].
Surgical Intervention: Surgical excision is often necessary for definitive diagnosis and treatment of neck masses, especially for neoplastic and congenital lesions [33]. FNA biopsy may be performed prior to surgery to obtain a tissue sample for histopathological examination and to guide further management decisions [29]. Surgical approaches vary depending on the location and nature of the neck mass, and may include open surgical excision, endoscopic approaches, or minimally invasive techniques [2]. For example, endoscopic or robotic-assisted surgery can provide precise removal of tumors with minimal disruption to surrounding tissues, which is particularly beneficial in the management of thyroid and salivary gland tumors [10].
Adjuvant Therapies: Adjuvant therapies such as radiation therapy and chemotherapy may be indicated for malignant neck masses, such as lymphoma and metastatic disease, to reduce the risk of recurrence and improve survival rates [34]. Targeted therapies, including immunotherapy and molecularly targeted agents, are emerging as promising treatment options for certain types of neck masses, particularly in cases of advanced or refractory disease [35]. For instance, monoclonal antibodies targeting specific cellular pathways have shown efficacy in treating certain head and neck cancers, offering new avenues for personalized treatment [36]. Supportive care, including nutritional support and pain management, is an important aspect of the management of neck masses, particularly for patients undergoing aggressive treatments such as surgery, radiation, or chemotherapy [37].
Follow-up: Regular follow-up is essential for patients with neck masses, especially those with a history of malignancy, to monitor for recurrence or progression of the disease [38]. Followup imaging studies and clinical examinations may be necessary to assess the response to treatment and to detect any new or recurrent lesions [39]. This may include periodic ultrasound, CT, or MRI scans, depending on the initial presentation and treatment plan. Additionally, surveillance protocols might incorporate biomarker assessments and routine blood tests to monitor overall health and detect early signs of recurrence [40].
Lastly, the management of neck masses requires a multidisciplinary approach involving otolaryngologists, radiologists, pathologists, and oncologists. Treatment strategies should be tailored to the individual patient based on the specific etiology and clinical characteristics of the neck mass, ensuring a comprehensive and personalized care plan that addresses all aspects of the patient’s condition.
Complications and Prognosis
Neck masses can be associated with various complications, depending on the underlying etiology and the extent of the disease. Potential complications include compression of adjacent structures, such as the airway, esophagus, and blood vessels, leading to symptoms such as dyspnea, dysphagia, and vascular compromise. Infections of neck masses can also occur, leading to abscess formation and systemic sepsis, which can necessitate urgent medical intervention to prevent life-threatening conditions [41].
The prognosis of neck masses depends on several factors, including the underlying etiology, the stage of the disease at diagnosis, and the patient’s overall health. Benign neck masses, such as reactive lymphadenopathy and cystic lesions, generally have a favorable prognosis with appropriate management [23]. However, malignant neck masses, such as lymphoma, thyroid cancer, and metastatic disease, can have a more guarded prognosis, particularly if diagnosed at an advanced stage. For example, early-stage thyroid cancers have high survival rates, whereas advanced metastatic cancers typically have poorer outcomes [12].
Early detection and timely intervention are crucial for improving the prognosis of neck masses, especially in cases of malignancy. Regular screening and monitoring in highrisk populations can aid in early detection and significantly enhance survival rates [42]. Multidisciplinary management involving specialists in otolaryngology, radiology, pathology, and oncology is often necessary to optimize treatment outcomes and minimize complications. This collaborative approach ensures comprehensive care, addressing all potential issues that may arise during the treatment course [22,43].
In summary, neck masses can be associated with various complications, including compression of adjacent structures and infections. The prognosis of neck masses depends on the underlying etiology and the stage of the disease at diagnosis. Early detection and appropriate management are essential for improving outcomes and minimizing complications.
Recent Advances, Progress, and Future Directions
Recent advances and progress in the diagnosis and management of neck masses have focused on improving diagnostic accuracy and treatment outcomes. Imaging modalities such as ultrasound, CT scan, and MRI have seen technological advancements, leading to improved resolution and better characterization of neck masses. Additionally, the use of molecular imaging techniques, such as PET, has enhanced the ability to differentiate between benign and malignant lesions, allowing for more targeted and effective treatment planning. For instance, the integration of advanced imaging protocols has reduced false-positive rates and improved early detection [6,23].
In the field of pathology, molecular and genetic studies have provided valuable insights into the molecular mechanisms underlying various types of neck masses. These advances have led to the identification of novel biomarkers and potential therapeutic targets, paving the way for personalized medicine approaches in the management of neck masses [44]. Recent progress includes the discovery of specific genetic mutations and protein expressions that correlate with prognosis and treatment response. For instance, genetic profiling of tumors can help in predicting response to specific therapies and in identifying patients who may benefit from novel targeted treatments [45].
Advancements in minimally invasive surgical techniques, such as endoscopic and robotic-assisted surgery, have revolutionized the management of neck masses, allowing for more precise and less invasive procedures with reduced morbidity. Recent progress in this area includes the development of new robotic platforms and enhanced endoscopic tools that provide better maneuverability and precision. These techniques enable surgeons to perform complex procedures with greater accuracy, reducing recovery time and improving cosmetic outcomes. This has been particularly beneficial in the treatment of thyroid and salivary gland tumors, where precision is critical [9].
Future research directions in the field of neck masses include further refinement of diagnostic techniques to improve early detection and characterization of lesions. Enhanced imaging modalities and the integration of artificial intelligence in diagnostic workflows are areas of active exploration, with the potential to significantly improve diagnostic accuracy [6]. Recent progress in AI applications has shown promise in automating the analysis of imaging results, leading to faster and more accurate diagnoses [46]. Biomarker discovery and validation are also areas of active research, with the aim of developing targeted therapies for specific subtypes of neck masses, potentially leading to more effective and less toxic treatment options [47]. Additionally, studies focusing on patient outcomes and quality of life following treatment are essential for optimizing treatment strategies and improving long-term prognosis. Such research can inform clinical guidelines and help in the development of holistic care plans that address both the medical and psychosocial needs of patients [8,34].
We can conclude by saying that recent advances in the diagnosis and treatment of neck masses have led to significant improvements in patient care. Future research efforts will continue to focus on further refining diagnostic techniques, identifying novel biomarkers, and developing targeted therapies to improve outcomes for patients with neck masses.
CONCLUSION
Neck masses present a diagnostic challenge due to their diverse etiologies and clinical presentations. A thorough clinical evaluation, including history taking, physical examination, and appropriate imaging studies, is essential for accurate diagnosis and management. Common diagnostic modalities used in the evaluation of neck masses include ultrasound, CT scan, MRI, and biopsy techniques.
Recent advances in imaging modalities, molecular pathology, and minimally invasive surgical techniques have significantly improved the diagnosis and management of neck masses. These advancements have led to better characterization of lesions, improved surgical outcomes, and the identification of potential therapeutic targets.
In clinical practice, early detection and timely intervention are crucial for improving patient outcomes, especially in cases of malignancy. A multidisciplinary approach involving specialists in otolaryngology, radiology, pathology, and oncology is often necessary to optimize treatment outcomes and minimize complications.
Future research efforts should focus on further refining diagnostic techniques, identifying novel biomarkers, and developing targeted therapies for specific subtypes of neck masses. Studies evaluating patient outcomes and quality of life following treatment are also essential for optimizing treatment strategies and improving long-term prognosis.
In conclusion, the management of neck masses requires a comprehensive approach that considers the diverse etiologies and clinical presentations of these lesions. Continued research and collaboration among healthcare professionals are essential for advancing our understanding and treatment of neck masses.
REFERENCES
- Pynnonen MA, Gillespie MB, Roman B, Rosenfeld RM, Tunkel DE, Bontempo L, et al. Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngology–Head and Neck Surg. 2017; 157: S30.
- Abraham ZS, Mathias M, Mapondella KB, Kahuna AA, Ntunaguzi D, Massawe ER. et al. Prevalence and aetiology of neck masses among patients receiving surgical services at Muhimbili National Hospital, Tanzania. Med J Zambia. 2019; 46: 4-60.
- Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci. 2023; 11: 42.
- Yan K, Agrawal N, Gooi Z. Head and Neck Masses. Med Clin North America. 2018; 102: 1013-1025.
- Tandon S, Shahab R, Benton JI, Ghosh SK, Sheard J, Jones TM. et al. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head & Neck: J for the Sciences and Specialties of the Head and Neck. 2008; 30: 1246-1252.
- Junn JC, Soderlund KA, Glastonbury CM. Imaging of head and neck cancer with CT, MRI, and US. Sem Nuclear Med. 2021.
- Eyassu E, Young M. Nuclear medicine PET/CT head and neck cancer assessment, protocols, and interpretation. 2023.
- Konings H, Stappers S, Geens M, De Winter BY, Lamote K, Van Meerbeeck JP, et al. A literature review of the potential diagnostic biomarkers of head and neck neoplasms. Front Oncol. 2020; 10: 1020.
- Holcomb AJ, Richmon JD. Robotic and endoscopic approaches to head and neck surgery. Hematology/Oncology Clinics. 2021; 35: 875-894.
- Nakayama M, Holsinger FC, Chevalier D, Orosco RK. The dawn of robotic surgery in otolaryngology-head and neck surgery. Japanese J Clin Oncol. 2019; 49: 404-411.
- Haynes J, Arnold KR, Aguirre-Oskins C, Chandra S. Evaluation of neck masses in adults. American family physician. 2015; 91: 698-706.
- Brown RE, Harave S. Diagnostic imaging of benign and malignant neck masses in children—a pictorial review. Quantitative Imaging Med Surg. 2016; 6: 591.
- LaPlante JK, Pierson NS, Hedlund GL. Common pediatric head and neck congenital/developmental anomalies. Radiologic Clin. 2015; 53:181-196.
- Bhayya H, Pavani D, Avinash Tejasvi ML, Geetha P. Oral lymphangioma: A rare case report. Contemporary Clin Dentistry. 2015; 6: 584-587.
- Schwetschenau E, Kelley DJ. The adult neck mass. American family physician. 2002; 66: 831-839.
- Glands S. Acute and Chronic Lymphadenitis. Introduction to Clinical Infectious Diseases: A Problem-Based Approach. 2019.
- Yu SC, Ko KY, Teng SC, Huang TC, Lo HT, Cheng CL, et al. A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus. Infectious Dis Ther. 2021; 10: 2661-2675.
- Greaves WO, Wang SA. Selected topics on lymphoid lesions in the head and neck regions. Head Neck Pathol. 2011; 5: 41-50.
- Khanlari M, Chapman JR. Follicular lymphoma: updates for pathologists. J Pathol Translational Med. 2022; 56: 1-15.
- Quintanilla-Dieck L, Penn EB. Congenital neck masses. Clinics Perinatol. 2018; 45: 769-785.
- Chorath K, Prasad A, Luu N, Go B, Moreira A, Rajasekaran K. Critical review of clinical practice guidelines for evaluation of neck mass in adults. Braz. 2022; 88: 625-632.
- Glen P, Botha E. Early detection and prevention of head and neck cancers. Br. Dent. J. 2022; 233: 726-730.
- Chorath K, Rajasekaran K. Evaluation and management of a neck mass. Medical Clinics. 2021; 105: 827-837.
- Wang SG. Differential diagnosis and treatment of neck masses. JKMA. 2007; 50: 613-625.
- Rauff S, Eng Kien T. Ultrasound diagnosis of fetal neck masses: a case series. Case Reports Obstetr Gynecol. 2013; 2013.
- Charan I, Kapoor A, Kumar N, Jagawat N, Singhal MK, Kumar HS. Evaluation of neck mass with computed tomography: an observational study. Int J Sci Stud. 2014; 2: 118-122.
- Wippold FJ. Head and neck imaging: the role of CT and MRI. Journal of Magnetic Resonance Imaging: An Official J ISMRM 2007; 25: 453-465.
- Liu ES, Bernstein JM, Sculerati N, Wu HC. Fine needle aspiration biopsy of pediatric head and neck masses. Int J Pediatr Otorhinolaryngol. 2001; 60:135-140.
- Mantri G, Jaiswal AA, Pal RK, Sharma N. Role of ultrasonography and fine-needle aspiration cytology in the evaluation of neck masses. Medical J Dr DY Patil University. 2020; 13: 486-497.
- Kalra A, Prucher G, Hodges S. The role of core needle biopsies in the management of neck lumps. Ann the Royal College of Surgeons of England. 2019; 101: 193-196.
- Brook I: Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses. J Oral Maxillofacial Surg. 2004; 62: 1545-1550.
- Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Supportive Care in Cancer. 2013; 21: 3179-3189.
- Dickson PV, Davidoff AM. Malignant neoplasms of the head and neck. Seminars Pediatr Surg. 2006.
- Tanadini-Lang S, Balermpas P, Guckenberger M, Pavic M, Riesterer O, Vuong D, et al. Radiomic biomarkers for head and neck squamous cell carcinoma. Strahlentherapie und Onkologie. 2020; 196: 868-878.
- Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol. 2015; 33: 3305-3313.
- Lee SC, López-Albaitero A, Ferris RL. Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies. Curr Oncol Rep. 2009; 11: 156-162.
- Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE, Wolden SL, Patel SG, et al Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience. Int J Radiat Oncol Biol Phys. 2007; 67: 691-702.
- Pagh A, Vedtofte T, Lynggaard CD, Rubek N, Lonka M, Johansen J, et al. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA. Acta Oncol. 2013; 52: 277- 284.
- Denaro N, Merlano MC, Russi EG. Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol. 2016; 9: 287-297.
- Hanna GJ, Patel N, Tedla SG, Baugnon KL, Aiken A, Agrawal N. Personalizing surveillance in head and neck cancer. Am Soc Clin Oncol Educ Book. 2023; 43: e389718.
- Boutakioute B, Benzalim M, Chehboun A, Ouali M, El Ganouni NCI. Spontaneous external jugular vein pseudoaneurysm: A rare cause of neck swelling. Radiol Case Rep. 2022; 17: 4790-4794.
- Gerstner AO. Early detection in head and neck cancer–current state and future perspectives. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008; 7: Doc06.
- Schutte HW, Heutink F, Wellenstein DJ, van den Broek GB, van den Hoogen FJ, Marres HA, et al. Impact of time to diagnosis and treatment in head and neck cancer: a systematic review. Otolaryngol Head Neck Surg. 2020; 162: 446-457.
- Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, et al. Molecular mechanism (s) of regulation (s) of c-MET/HGF signaling in head and neck cancer. Mol Cancer. 2022; 21: 31.
- Sahu N, Grandis JR. New advances in molecular approaches to head and neck squamous cell carcinoma. Anti-cancer Drugs. 2011; 22: 656-664.
- Mahmood H, Shaban M, Rajpoot N, Khurram SA. Artificial Intelligence- based methods in head and neck cancer diagnosis: an overview. Br J Cancer. 2021; 124: 1934-1940.
- Schanne DH, Koch A, Elicin O, Giger R, Medová M, Zimmer Y, et al. Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review. Biomedicines. 2022; 10: 3288.